Baxter International (BAX): Officer had shares withheld for tax 650 shares
Jeanne K Mason, Officer at Baxter International, reported a tax withholding of 650 shares.
- 650
- Shares · @ $19.15
- Traded
- Dec 12, 2025
- Filed
- Dec 16, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 25, 2025CongressDisclosed purchase of BAX — reported range $1,001 - $15,000
- Oct 16, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 16, 2025, Heather Knight notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Executive Vice President, Chief Operating Officer (“COO”) and interim group president of Medical Products and Therapies (“MPT”), effective as of October 29, 2025 (the “Transition Date”), to join a company in the healthcare industry.”
- Oct 16, 2025Court · District Court, N.D. IllinoisSecurities lawsuit filed: Electrical Workers Pension Fund, Local 103 IBEW v. Baxter International, Inc.
- Oct 17, 20255% stakeBlackRock Portfolio Management LLC reported a passive stake (13G) of 7.6%
- Oct 28, 2025FDARecall: Welch Allyn INF BAG, Thigh 1-Tube, Model/Catalog Number: REF 5089-18; Product replacement bladder for the Welch Allyn Two-Piece Blood Pressure Cuff.
- Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
- Oct 31, 2025CongressDisclosed sale of BAX — reported range $1,001 - $15,000
- Nov 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 5, 2025, Alok Sonig notified Baxter International Inc. (the “Company”) of his decision to resign as the Company’s Executive Vice President and Group President, Pharmaceuticals, effective as of December 1, 2025, to join a company in the healthcare industry.”
- Nov 13, 20255% stakeDodge & Cox reported a passive stake (13G) of 11.2%
- Nov 24, 2025Government · Federal Register ruleMedicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model
- Nov 25, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
- Nov 28, 2025FDARecall: SIGMA Spectrum Infusion Pump, Model/Catalog Number: 35700BAX2
- Dec 3, 2025Court · District Court, N.D. IllinoisSecurities lawsuit filed: City of Hallandale Beach Police Officers' and Firefighters' Personnel Retirement Trust v. Baxter International, Inc.
- Dec 4, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
What came next
- Dec 16, 2025FDAFDA device clearance: Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs)
- Dec 22, 2025FDARecall: Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02.
- Jan 13, 2026FDARecall: Brand Name: Spectrum IQ Product Name: Infusion Pump Model/Catalog Number: 3570009 Software Version: N/A Product Description: Infusion Pump, one unit per carton…
- Jan 16, 2026FDAFDA device clearance: WAVE Clinical Platform (2.0.000)
- Jan 21, 20265% stakePZENA INVESTMENT MANAGEMENT LLC reported a passive stake (13G) of 13.8%
- Jan 21, 20265% stakeBlackRock Portfolio Management LLC reported a passive stake (13G) of 8.7%
- Feb 5, 20265% stakeFMR LLC reported a passive stake (13G) of 6.8%
- Feb 10, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On February 10, 2026, Baxter International Inc. (the “Company”) appointed Michael R. McDonnell to its Board of Directors (the “Board”), effective February 13, 2026.”
- Feb 18, 2026FDARecall: Blue Ventilator Adapter Module, single-patient use circuit, Product Code M07937. Accessory to Baxter Volara Respiratory Therapy system.
- Feb 18, 2026FDARecall: Brand Name: Welch Allyn, Inc. Product Name: Welch Allyn Spot Vision Screener VS100 Model/Catalog Number: VS100 Software Version: Software version 3.2.0.1 Produ…
- Feb 26, 2026FDAFDA drug approval: Phytonadione
- Mar 15, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 16, 2026, Baxter International Inc. (the “Company”) announced that, as of such date (the “Transition Date”), Joel Grade’s service as Executive Vice President and Chief Financial Officer (“CFO”) of the Company has ceased and, as of such date, Mr. Grade has transitioned into a non-executive officer role and will continue employment with the Company in an advisory capacity through April 30, 2026.”
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 30, 2026FDAFDA drug approval: Epinephrine
- Apr 3, 2026FDAFDA drug approval: Phenylephrine Hydrochloride
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Baxter International
For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BAX page.
How this filing works
Explore the data
Common questions
Which Baxter International (BAX) insider traded, and how much?
Jeanne K Mason, Officer at Baxter International, reported a tax withholding of 650 shares. At $19.15.
When did it happen, and when was it made public?
Traded: Dec 12, 2025. Filed: Dec 16, 2025. That is 4 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Baxter International recently?
For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BAX page.
Does this mean BAX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Baxter International
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRAug 11, 2026
Everything OQRO holds on this company is on its BAX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
